Enact Holdings, Inc.
Enact (ACT) reported Q2 2026 adjusted operating income of $177 million, or $1.26 per diluted share, up from $174 million, or $1.15, in Q2 2025. New insurance written rose 15% to $15 billion. FY2026 capital return guidance was raised to $550 million to $600 million. Management cited $274 billion insurance in force and 161% PMIERs sufficiency.
Enact Holdings (NASDAQ: ACT) reported Q2 CY2026 results. Revenue rose 1.6% year on year to $317.3 million and matched Wall Street expectations, according to the article. Non-GAAP profit was $1.26 per share, 6.1% above analysts’ consensus. The stock was flat at $47.82 after the release.
Enact Holdings, Inc. (ACT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2q26earningsrelease.htm EX-99.1 Document Exhibit 99.1 ENACT REPORTS SECOND QUARTER 2026 RESULTS; ANNOUNCES $0.24 QUARTERLY DIVIDEND _______________________________________ GAAP Net Income of $175 million, or $1.25 per diluted share Adjusted Operating Income of $177 mil
Over the past 7 days, alphai's AI scored 1 news story mentioning ACT (Enact Holdings, Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent ACT coverage spans earnings, insider activity and financial news.
In the last 30 days, ACT insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($24.0M). The most active reporter was Genworth Holdings, Inc. with 1 filing.
Guidance uplift plus capital return range revision is the primary near-term catalyst, partially offset by management warning of rising delinquencies in 2H26.
Results appear broadly in-line on revenue with a modest EPS beat, suggesting limited upside surprise versus expectations.
Quarterly earnings, capital return guidance, and dividend declaration create a near-term catalyst for ACT’s valuation and capital-return expectations.
This is an earnings preview with limited new fundamentals, but it frames the key risk around revenue misses versus reconfirmed estimates.
The filing is a large insider open-market sale, which can modestly pressure sentiment but is not a fundamental change by itself.
alphai scores every news story that mentions ACT with an AI model for sentiment and relevance, and aggregates insider trades from Enact Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Enact (ACT) reported Q2 2026 adjusted operating income of $177 million, or $1.26 per diluted share, up from $174 million, or $1.15, in Q2 2025. New insurance written rose 15% to $15 billion. FY2026 capital return guidance was raised to $550 million to $600 million. Management cited $274 billion insurance in force and 161% PMIERs sufficiency.
9 min readEnact Holdings (NASDAQ: ACT) reported Q2 CY2026 results. Revenue rose 1.6% year on year to $317.3 million and matched Wall Street expectations, according to the article. Non-GAAP profit was $1.26 per share, 6.1% above analysts’ consensus. The stock was flat at $47.82 after the release.
3 min readEnact Holdings, Inc. (ACT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2q26earningsrelease.htm EX-99.1 Document Exhibit 99.1 ENACT REPORTS SECOND QUARTER 2026 RESULTS; ANNOUNCES $0.24 QUARTERLY DIVIDEND _______________________________________ GAAP Net Income of $175 million, or $1.25 per diluted share Adjusted Operating Income of $177 mil
6 min readEnact Holdings (ACT) will report Q2 earnings Wednesday after the bell. The company previously reported $317.9 million revenue, up 2.5% year on year, with a narrow EPS beat. For the upcoming quarter, analysts expect revenue to rise 1.3% year on year. The article cites an average analyst price target of $46 versus $47.91.
2 min readGenworth Holdings, Inc. sold 523,226 shares of Enact Holdings, Inc. (ACT) at $45.92 ($24.03M total) on 2026-07-31.
2 min readGenworth Holdings, Inc. sold 605,067 shares of Enact Holdings, Inc. (ACT) at $42.28 ($25.58M total) on 2026-06-30.
3 min readGould Brian (EVP & Chief Operations Officer) sold 23,000 shares of Enact Holdings, Inc. (ACT) at $41.18 ($0.95M total) on 2026-06-01.
1 min readGenworth Holdings, Inc. sold 602,440 shares of Enact Holdings, Inc. (ACT) at $42.91 ($25.85M total) on 2026-05-29.
3 min readEvan Stolove, EVP, General Counsel, and Secretary of Enact Holdings, Inc. (ACT), was granted three small awards of restricted stock units (RSUs) on March 19, 2026. These RSUs convert to common stock on a 1:1 basis and vest in three annual installments starting in 2025, 2026, and 2027. A portion of these awards are tied to dividend reinvestment from a quarterly dividend paid on the same date, representing routine compensation and not involving any share sales.
1 min readEnact Holdings director Westley V. Thompson was awarded 162 Deferred Stock Units with a value of $0.21 per share through a dividend reinvestment plan. This transaction, filed on a Form 4, increased his total holdings to 30,705.457 Deferred Stock Units. These units will be convertible into common stock one year after his termination of service as a director for the company.
2 min read
